Parecoxib
Top View
- World Journal of Pharmaceutical Research Rafik Et Al
- Parecoxibinj.Pdf
- DYNASTAT® (Die-Na-Stat) Parecoxib Consumer Medicine Information
- (COX-2) Inhibitor Medicines
- Comparison of Nsaids Activity in COX‑2 Expressing and Non‑Expressing 2D and 3D Pancreatic Cancer Cell Cultures
- Non-Steroidal Anti-Inflammatory Drugs (Nsaids) for Chronic Non-Cancer Pain in Children and Adolescents (Review)
- JIA Guideline Appendix 4
- Decisional Summary
- Parecoxib Trade Name: DYNASTAT CDS Effective Date: November 01, 2019 Supersedes: August 14, 2018 Approved by BPOM:April 18, 2020 PT
- Parecoxib Sodium Injection (Dynastat Injection)
- Dynastat® (Parecoxib Sodium) 40 Mg Powder for Solution for Injection
- European Patent Office
- Medicines Adverse Reactions Committee
- Nsaids in the Acute Treatment of Migraine: a Review of Clinical and Experimental Data
- Safety Review: Nonsteroidal Anti-Inflammatory Drugs (Nsaids) and Spontaneous Abortion
- Review Search Strategy
- Non Steroidal Anti-Inflammatory Drugs (Nsaids) and Cox-2 Inhibitors in the Acute Post Operative Pain Setting
- Package Leaflet: Information for the User